Çdzª½ºÅ׸®µå ½ÃÀå Á¡À¯À², ±Ô¸ð, µ¿Çâ, »ê¾÷ ºÐ¼® º¸°í¼­ : Á¦Ç°º°, ¿ëµµº°, À¯Åë ä³Îº°, Áö¿ªº°, ºÎ¹®º° ¿¹Ãø(2024-2032³â)
Finasteride Market Share, Size, Trends, Industry Analysis Report, By Product (1mg, 5mg); By Application; By Distribution Channel; By Region; Segment Forecast, 2024 - 2032
»óǰÄÚµå : 1449448
¸®¼­Ä¡»ç : Polaris Market Research
¹ßÇàÀÏ : 2024³â 02¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 118 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,250 £Ü 6,031,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 5,250 £Ü 7,450,000
PDF (Multi User License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ 20¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,250 £Ü 8,869,000
PDF (Enterprise License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

Polaris Market ResearchÀÇ ÃֽŠ¿¬±¸¿¡ µû¸£¸é Çdzª½ºÅ׸®µå ¼¼°è ½ÃÀå ±Ô¸ð´Â 2032³â±îÁö 1¾ï 2,877¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ º¸°í¼­´Â ÇöÀç ½ÃÀå ¿ªÇп¡ ´ëÇÑ ÀÚ¼¼ÇÑ ÀλçÀÌÆ®¿Í ÇâÈÄ ½ÃÀå ¼ºÀå¿¡ ´ëÇÑ ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.

½ÃÀå¿¡¼­ Çdzª½ºÅ׸®µå¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡´Â ³²¼ºÀÇ ´ë¸Ó¸®¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁ³±â ¶§¹®ÀÎ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù. ³²¼ºÀÇ °æ¿ì 30¼¼¿¡ ´ë¸Ó¸® ¡Èİ¡ ³ªÅ¸³ª°í 60¼¼±îÁö ¿ÏÀüÈ÷ ´ë¸Ó¸®°¡ µÇ´Â À¯º´·üÀÌ ³ô¾ÆÁö¸é¼­ ¸ð¹ß ÀÌ½Ä ¹× °ü¸®¿¡ ´ëÇÑ ½Ã´ëÀû ¿ä±¸°¡ ³ô¾ÆÁö°í ÀÖ½À´Ï´Ù. Çdzª½ºÅ׸®µå´Â µÎÇÇÀÇ ³²¼ºÈ£¸£¸ó ¼ºÀåÀ» ¾ïÁ¦ÇÏ¿© Å»¸ðÁõ Ä¡·á¿¡ È¿°ú°¡ ÀÖ´Â °ÍÀ¸·Î ¾Ë·ÁÁö¸é¼­ ½ÃÀå¿¡¼­ÀÇ Ã¤ÅÃÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù.

¶ÇÇÑ, ³²¼º °Ç°­¿¡ ´ëÇÑ Çdzª½ºÅ׸®µåÀÇ ÀÌÁ¡À» Æò°¡ÇÏ´Â ¿¬±¸ÀÚµéÀÇ Áõ°¡µµ ½ÃÀå ¼ºÀå¿¡ ±àÁ¤ÀûÀÎ ¿µÇâÀ» ¹ÌÄ¡°í ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, PubMed Central¿¡ °ÔÀçµÈ 2023³â ¿¬±¸´Â Àü¸³¼± ºñ´ëÁõ¿¡ ´ëÇÑ Çdzª½ºÅ׸®µåÀÇ Àå±âÀûÀÎ È¿°ú¿¡ ÃÊÁ¡À» ¸ÂÃá ¿¬±¸·Î, Àü¸³¼± ºñ´ëÁõ°ú ¿äÆó°¡ ÀÖ´Â ³²¼º¿¡°Ô 4³â°£ Çdzª½ºÅ׸®µå¸¦ Åõ¿©ÇÏ¸é ¼Òº¯ÀÇ È帧À» ÃËÁøÇÏ°í ±Þ¼º ¿äÆó ¹× ¼ö¼ú °¡´É¼ºÀ» ³·Ãá´Ù´Â °á·ÐÀ» ³»·È½À´Ï´Ù. ÀÌ ³·¾ÆÁø´Ù´Â °á·ÐÀ» ³»·È½À´Ï´Ù. ´õ ¸¹Àº »ç¶÷µéÀÌ Çdzª½ºÅ׸®µåÀÇ °Ç°­ °ü¸® ÀÌÁ¡À» ÀνÄÇÔ¿¡ µû¶ó ÇâÈÄ ¸î ³â µ¿¾È ¼ö¿ä°¡ ±ÞÁõÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¶ÇÇÑ, Á¦¾à»ç¿Í ÇÐÀÚµéÀÇ Çdzª½ºÅ׸®µå Á¤Á¦ °æ±¸ º¹¿ë°ú °ü·ÃµÈ ºÎÀÛ¿ë¿¡ ´ëÀÀÇϱâ À§ÇÑ ¿¬±¸°¡ ÁøÇàµÇ°í ÀÖ´Â °Íµµ ½ÃÀå È®´ë¿¡ ÈûÀ» º¸Å°í ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, 2023³â 3¿ù º¸·ÉÁ¦¾àÀº ±¹³» ÃÖÃÊ·Î ½ºÇÁ·¹ÀÌÇü Çdzª½ºÅ׸®µå ¼ººÐÀÇ Å»¸ð Ä¡·áÁ¦¸¦ Ãâ½ÃÇϱ⵵ Çß½À´Ï´Ù. ÀÌ·¯ÇÑ ±â¼ú Çõ½ÅÀº ´çºÐ°£ ½ÃÀå¿¡¼­ Çdzª½ºÅ׸®µåÀÇ ¼ö¿ä¸¦ ÀÚ±ØÇÒ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù.

¶ÇÇÑ, Çdzª½ºÅ׸®µåÀÇ Æ¯¼ºÀ» ޱ¸ÇÏ´Â ÁøÇà ÁßÀÎ ¿¬±¸ Ȱµ¿Àº ½ÃÀå¿¡¼­ »õ·Î¿î ¼ºÀå ±âȸ¸¦ âÃâÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¿¹¸¦ µé¾î, Science Direct¿¡ °ÔÀçµÈ 2023³â ¿¬±¸´Â ¾Èµå·Î°Õ¼º Å»¸ðÁõ Ä¡·á¿¡¼­ °æ±¸¿ë Çdzª½ºÅ׸®µåÀÇ ºÎÀÛ¿ëÀ» ±Øº¹Çϱâ À§ÇØ ¸ð³¶À» Ç¥ÀûÀ¸·Î ÇÏ´Â ±¹¼Ò Çdzª½ºÅ׸®µå ´Ï¿ÀÁ»ÀÇ °³¹ß¿¡ ÃÊÁ¡À» ¸ÂÃß°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ °³¹ßÀº ºÎÀÛ¿ëÀÌ Àû°í È¿À²ÀûÀÎ Å»¸ð Ä¡·áÁ¦ÀÇ °³¹ß·Î ȯÀÚµéÀÇ ¼ö¿ä¸¦ È®º¸ÇÒ ¼ö ÀÖÀ» °ÍÀ¸·Î ±â´ëµË´Ï´Ù.

Çdzª½ºÅ׸®µå ½ÃÀå º¸°í¼­ ÇÏÀ̶óÀÌÆ®

Å»¸ð·Î °í¹ÎÇÏ´Â ³²¼º Àα¸°¡ ¸¹±â ¶§¹®¿¡ 1mg ºÎ¹®Àº ÇâÈÄ ¸î ³â µ¿¾È °¡Àå ³ôÀº ¼ºÀåÀ» º¸ÀÏ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

Àü¸³¼± ºñ´ëÁõ°ú °°Àº Áúº´À» ¾ïÁ¦ÇÏ´Â µ¥ È¿°úÀûÀ̱⠶§¹®¿¡ Àü¸³¼± ºñ´ëÁõ ºÎ¹®ÀÌ 2023³â °¡Àå Å« ½ÃÀå Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù.

¼Ò¸Å ¾à±¹ ºÎ¹®Àº ÀǾàǰ À¯ÅëÀÇ Á¢±Ù¼º°ú ÆíÀǼº Çâ»óÀ¸·Î ÀÎÇØ 2023³â ÁÖ¿ä ½ÃÀå Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù.

¾Æ½Ã¾ÆÅÂÆò¾çÀº ¿¹Ãø ±â°£ µ¿¾È °¡Àå ºü¸¥ ¼ºÀåÀ» ±â·ÏÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ´Â ¾Æ½Ã¾Æ Àα¸ÀÇ ´ë´Ù¼ö, ƯÈ÷ ³²¼ºÀÇ Å»¸ð ¹ß»ý·üÀÌ Áõ°¡Çϰí Àֱ⠶§¹®ÀÔ´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¼Ò°³

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå Á¶»ç ¹æ¹ý

Á¦4Àå ¼¼°èÀÇ Çdzª½ºÅ׸®µå ½ÃÀå¿¡ °üÇÑ ÀλçÀÌÆ®

Á¦5Àå ¼¼°èÀÇ Çdzª½ºÅ׸®µå ½ÃÀå, Á¦Ç°º°

Á¦6Àå ¼¼°èÀÇ Çdzª½ºÅ׸®µå ½ÃÀå, ¿ëµµº°

Á¦7Àå ¼¼°èÀÇ Çdzª½ºÅ׸®µå ½ÃÀå, À¯Åë ä³Îº°

Á¦8Àå ¼¼°èÀÇ Çdzª½ºÅ׸®µå ½ÃÀå, Áö¿ªº°

Á¦9Àå °æÀï »óȲ

Á¦10Àå ±â¾÷ °³¿ä

ksm
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

The global finasteride market size is expected to reach USD 128.77 million by 2032, according to a new study by Polaris Market Research. The report "Finasteride Market Share, Size, Trends, Industry Analysis Report, By Product (1mg, 5mg); By Application; By Distribution Channel; By Region; Segment Forecast, 2023 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The increasing demand for finasteride in the marketplace can be attributable to the growing concerns about baldness among males. The prevalence of baldness signs among men at the age of 30 and complete baldness by 60 is driving the need of the hour for hair implantation and care. The potential of finasteride medication in the treatment of pattern hair loss by restricting the growth of male hormones at the scalp in the body is boosting its adoption in the marketplace.

Furthermore, rising researchers focus on evaluating the benefits of finasteride for male health is positively impacting market growth. For instance, a 2023 study published in PubMed Central focused on finding the long-term effects of finasteride in benign prostatic hyperplasia and concluded that the treatment of finasteride for four years among men experiencing urinary obstruction and prostatic enlargement promoted the rate of urinary flow and a lower chance of acute urinary retention and surgery. As more people identify the healthcare benefits of finasteride, there will be an upsurge in its demand in the next few years.

In addition, the evolving research studies to counter the side effects associated with the oral intake of finasteride pills by pharmaceutical companies and academicians are boosting market expansion. For instance, in March 2023, Boryung Company unveiled the initial spray-type finasteride-based hair loss drug in Korea. These innovations are likely to stimulate the demand for finasteride in the marketplace in the foreseeable future.

Moreover, the ongoing research activities delving into the properties of finasteride are projected to enhance new growth opportunities in the marketplace. For instance, a 2023 study published in Science Direct focused on the development of topical finasteride niosomes targeting hair follicles to overcome the oral finasteride side effects for the treatment of androgenic alopecia. These types of developments are expected to gain demand from patients, driven by the development of efficient hair loss treatments with lower side effects.

Finasteride Market Report Highlights

1mg segment is anticipated to witness the highest growth in the coming years due to the presence of a larger number of men's population suffering from hair loss.

Prostate enlargement segment accounted for the largest market share in 2023, owing to its effective performance in controlling the disease such as prostate enlargement.

Retail pharmacies segment held a major market share in 2023, due to its enhanced accessibility and convenience in distribution of medicines.

Asia Pacific is projected to register the fastest growth during the forecast period, attributable to the rising incidence of hair fall among larger section of the Asian populations specifically among men.

The global players include Accord Pharmaceuticals, Actavis, Cipla, Henan Topfond, Merck, Mylan N.V., RelonChem, Sandoz, Teva Pharmaceuticals, and others.

Polaris Market Research has segmented the finasteride market report based on product, application, distribution channel and region:

Finasteride, Product Outlook (Revenue - USD Million, 2019 - 2032)

Finasteride, Application Outlook (Revenue - USD Million, 2019 - 2032)

Finasteride, Distribution Channel Outlook (Revenue - USD Million, 2019 - 2032)

Finasteride, Regional Outlook (Revenue - USD Million, 2019 - 2032)

Table of Contents

1. Introduction

2. Executive Summary

3. Research Methodology

4. Global Finasteride Market Insights

5. Global Finasteride Market, by Product

6. Global Finasteride Market, by Application

7. Global Finasteride Market, by Distribution Channel

8. Global Finasteride Market, by Geography

9. Competitive Landscape

10. Company Profiles

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â